Marić Alena, Scherf Katharina Anne
Department of Bioactive and Functional Food Chemistry, Institute of Applied Biosciences, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Front Nutr. 2021 Jul 20;8:712992. doi: 10.3389/fnut.2021.712992. eCollection 2021.
A strict lifelong gluten-free (GF) diet is currently the only known effective treatment for celiac disease (CD), an inflammatory disorder of the small intestine with a worldwide prevalence of about 1%. CD patients need to avoid wheat, rye, and barley and consume GF foods containing <20 mg/kg of gluten. However, strict adherence to a GF diet tends to reduce the quality of life of CD patients compared to the general population and may lead to fear of inadvertent gluten consumption, especially when eating out. To help alleviate risk of gluten exposure, a portable gluten sensor was developed by Nima Labs that allows CD patients to test foods on site prior to consumption. With very limited independent information on the analytical performance of the Nima sensor available so far, our aim was to evaluate the reliability of the sensor using a variety of different foods with defined gluten content. All samples were tested with the sensor and analyzed by enzyme-linked immunosorbent assay as reference method. Of the 119 samples with gluten content ranging from 2 to 101,888 mg/kg tested in total, the sensor showed 80 positive (67.2%), 37 negative (31.1%) and 2 invalid results at the first of three consecutive measurements. The detection rate for samples containing ≥20 mg/kg of gluten was 90%. Samples containing 2 mg/kg of gluten or below consistently tested negative, but samples with a gluten content between 2 to 20 mg/kg of gluten may either test positive or negative. Overall, the performance of the sensor was acceptable in our study, but we observed systematic variation between different users that also appeared to depend on the sample being tested. This highlights the need to improve user education especially regarding the effect of sampling, testing limitations in case of partially hydrolyzed, fractionated or fermented gluten and training users on how to perform the test in a way that gluten will be reliably detected.
严格的终身无麸质(GF)饮食是目前已知的唯一有效治疗乳糜泻(CD)的方法,乳糜泻是一种小肠炎症性疾病,全球患病率约为1%。CD患者需要避免食用小麦、黑麦和大麦,并食用麸质含量低于20毫克/千克的GF食品。然而,与普通人群相比,严格坚持GF饮食往往会降低CD患者的生活质量,并且可能导致对无意中摄入麸质的恐惧,尤其是在外出就餐时。为了帮助降低麸质暴露风险,Nima实验室开发了一种便携式麸质传感器,使CD患者能够在食用前现场检测食物。由于目前关于Nima传感器分析性能的独立信息非常有限,我们的目的是使用各种麸质含量明确的不同食物来评估该传感器的可靠性。所有样品都用该传感器进行了测试,并通过酶联免疫吸附测定作为参考方法进行了分析。在总共测试的119个麸质含量从2到101,888毫克/千克的样品中,该传感器在连续三次测量的第一次测量中显示出80个阳性结果(67.2%)、37个阴性结果(31.1%)和2个无效结果。麸质含量≥20毫克/千克的样品的检测率为90%。麸质含量为2毫克/千克或更低的样品始终检测为阴性,但麸质含量在2至20毫克/千克之间的样品可能检测为阳性或阴性。总体而言,在我们的研究中该传感器的性能是可以接受的,但我们观察到不同用户之间存在系统差异,这似乎也取决于所测试的样品。这突出表明需要加强用户教育,特别是关于采样的影响、部分水解、分级或发酵麸质情况下的测试局限性,以及培训用户如何以可靠检测麸质的方式进行测试。